Diebold Nixdorf (DBD) Cash & Equivalents (2009 - 2026)

Diebold Nixdorf (DBD) has reported Cash & Equivalents for 18 consecutive years, with $282.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents fell 4.34% year-over-year to $282.4 million; the trailing twelve-month figure through Jun 2026 stood at $282.4 million (down 4.34% YoY), and the FY2025 full-year result was $387.3 million, up 24.41% from the prior year.
• Cash & Equivalents fell to $282.4 million in Q2 2026 per DBD's latest filing, from $373.6 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $592.3 million in Q4 2023 and bottomed at $128.4 million in Q3 2022.
• Historically, Cash & Equivalents has averaged $314.2 million across 5 years, with a median of $288.8 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents surged 192.91% in 2023, then tumbled 47.44% in 2024.
• Over 5 years, Cash & Equivalents stood at $319.1 million in 2022, then soared by 85.62% to $592.3 million in 2023, then sank by 47.44% to $311.3 million in 2024, then grew by 24.41% to $387.3 million in 2025, then decreased by 27.08% to $282.4 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $282.4 million, $373.6 million, and $387.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.